|
BCAX Bicara Therapeutics Inc 2023658 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-56,211,000.00 |
| Balance Sheet |
|
Current Assets
|
$544,915,000.00 |
|
Assets
|
$553,599,000.00 |
|
Current Liabilities
|
$39,340,000.00 |
|
Liabilities
|
$39,641,000.00 |
|
Equity
|
$513,958,000.00 |
|
Shares Out
|
65547037.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-37,508,000.00 |
|
Investing Cash Flow
|
$100,940,000.00 |
| Market Analysis |
Market Cap
|
$1,721,920,661.99 |
|
Price
|
$26.29 |
|
BVPS
|
7.84 |
|
PB
|
3.35 |
|
EPS
|
-0.93 |
|
FCF
|
$-37,568,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:24 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:19 |
|
| Apr |
May |
Jun |
| 2026-03-30 |
-0.68 |
|
|
2026-05-11 |
-0.93 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-12 |
-0.50 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-10 |
-0.67 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view BCAX documents filed with the SEC.
BCAX Filings
Clear
